Shanghai Fosun Pharmaceutical Group Co Ltd (600196) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.038x

Based on the latest financial reports, Shanghai Fosun Pharmaceutical Group Co Ltd (600196) has a cash flow conversion efficiency ratio of 0.038x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥2.40 Billion ≈ $350.75 Million USD) by net assets (CN¥62.49 Billion ≈ $9.14 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Shanghai Fosun Pharmaceutical Group Co L for the company's overall valuation and market capitalisation.

Shanghai Fosun Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Shanghai Fosun Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shanghai Fosun Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Fosun Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency. Explore 600196 cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Kesko Oyj HE:KESKOB	0.103x
Noble Corporation plc NYSE:NE	0.060x
3Peak Inc SHG:688536	0.011x
Osisko Gold Ro TO:OR	0.059x
HealthEquity Inc NASDAQ:HQY	0.056x
Hyundai Autoever Corp KO:307950	0.025x
Far East Smarter Energy Co Ltd SHG:600869	0.019x
HITACHI CONSTR.MACH.ADR/2 F:HCMA	N/A

Annual Cash Flow Conversion Efficiency for Shanghai Fosun Pharmaceutical Group Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Fosun Pharmaceutical Group Co Ltd from 1998 to 2025. View latest Shanghai Fosun Pharmaceutical Group Co L stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥62.49 Billion ≈ $9.14 Billion	CN¥6.01 Billion ≈ $878.76 Million	0.096x	+28.64%
2024-12-31	CN¥59.93 Billion ≈ $8.77 Billion	CN¥4.48 Billion ≈ $655.12 Million	0.075x	-3.07%
2023-12-31	CN¥56.62 Billion ≈ $8.28 Billion	CN¥4.36 Billion ≈ $638.48 Million	0.077x	-1.13%
2022-12-31	CN¥54.11 Billion ≈ $7.92 Billion	CN¥4.22 Billion ≈ $617.16 Million	0.078x	-4.51%
2021-12-31	CN¥48.38 Billion ≈ $7.08 Billion	CN¥3.95 Billion ≈ $577.83 Million	0.082x	+45.50%
2020-12-31	CN¥45.98 Billion ≈ $6.73 Billion	CN¥2.58 Billion ≈ $377.50 Million	0.056x	-31.75%
2019-12-31	CN¥39.20 Billion ≈ $5.74 Billion	CN¥3.22 Billion ≈ $471.54 Million	0.082x	-6.40%
2018-12-31	CN¥33.59 Billion ≈ $4.92 Billion	CN¥2.95 Billion ≈ $431.69 Million	0.088x	+1.23%
2017-12-31	CN¥29.74 Billion ≈ $4.35 Billion	CN¥2.58 Billion ≈ $377.57 Million	0.087x	+3.82%
2016-12-31	CN¥25.25 Billion ≈ $3.69 Billion	CN¥2.11 Billion ≈ $308.77 Million	0.084x	+6.55%
2015-12-31	CN¥20.67 Billion ≈ $3.02 Billion	CN¥1.62 Billion ≈ $237.21 Million	0.078x	+24.82%
2014-12-31	CN¥19.10 Billion ≈ $2.80 Billion	CN¥1.20 Billion ≈ $175.63 Million	0.063x	+9.71%
2013-12-31	CN¥17.66 Billion ≈ $2.58 Billion	CN¥1.01 Billion ≈ $148.03 Million	0.057x	+31.70%
2012-12-31	CN¥15.30 Billion ≈ $2.24 Billion	CN¥665.52 Million ≈ $97.39 Million	0.043x	+56.15%
2011-12-31	CN¥11.37 Billion ≈ $1.66 Billion	CN¥316.65 Million ≈ $46.34 Million	0.028x	+28.63%
2010-12-31	CN¥9.39 Billion ≈ $1.37 Billion	CN¥203.36 Million ≈ $29.76 Million	0.022x	-42.52%
2009-12-31	CN¥6.95 Billion ≈ $1.02 Billion	CN¥261.87 Million ≈ $38.32 Million	0.038x	-28.14%
2008-12-31	CN¥4.45 Billion ≈ $650.58 Million	CN¥233.04 Million ≈ $34.10 Million	0.052x	+72.08%
2007-12-31	CN¥4.32 Billion ≈ $631.62 Million	CN¥131.48 Million ≈ $19.24 Million	0.030x	-39.90%
2006-12-31	CN¥3.65 Billion ≈ $533.90 Million	CN¥184.91 Million ≈ $27.06 Million	0.051x	-22.64%
2005-12-31	CN¥2.88 Billion ≈ $420.71 Million	CN¥188.35 Million ≈ $27.56 Million	0.066x	-10.12%
2004-12-31	CN¥2.81 Billion ≈ $411.75 Million	CN¥205.10 Million ≈ $30.01 Million	0.073x	-2.08%
2003-12-31	CN¥2.02 Billion ≈ $295.14 Million	CN¥150.14 Million ≈ $21.97 Million	0.074x	+21.56%
2002-12-31	CN¥1.67 Billion ≈ $244.87 Million	CN¥102.47 Million ≈ $15.00 Million	0.061x	+18.84%
2001-12-31	CN¥1.32 Billion ≈ $193.54 Million	CN¥68.15 Million ≈ $9.97 Million	0.052x	-54.64%
2000-12-31	CN¥1.22 Billion ≈ $178.30 Million	CN¥138.43 Million ≈ $20.26 Million	0.114x	+95.42%
1999-12-31	CN¥657.08 Million ≈ $96.15 Million	CN¥38.20 Million ≈ $5.59 Million	0.058x	-53.64%
1998-12-31	CN¥530.77 Million ≈ $77.67 Million	CN¥66.55 Million ≈ $9.74 Million	0.125x	--

About Shanghai Fosun Pharmaceutical Group Co Ltd

SHG:600196 China Drug Manufacturers - Specialty & Generic

Market Cap

$7.17 Billion

CN¥49.00 Billion CNY

Market Cap Rank

#2855 Global

#353 in China

Share Price

CN¥23.13

Change (1 day)

+0.35%

52-Week Range

CN¥21.21 - CN¥30.34

All Time High

CN¥85.06